# American Homes 4 Rent: financial statements, quarterly

AMH · NYSE · CIK 1562401 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amh.md) · [Financials](/companies/amh/financials.md) · [Filings](/companies/amh/filings.md) · [Insiders](/companies/amh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [34.4](/filings/0001562401-24-000082.md) | [35.1 d](/filings/0001562401-26-000010.md) | [38.6](/filings/0001562401-25-000037.md) | [38.7](/filings/0001562401-25-000067.md) | [43.6](/filings/0001562401-25-000082.md) | [44.5 d](/filings/0001562401-26-000010.md) | [45.4](/filings/0001562401-26-000032.md) | [46.3](/filings/0001562401-26-000047.md) | [48.2](/filings/0001562401-25-000082.md) | [45.3 d](/filings/0001562401-26-000010.md) | [48.2](/filings/0001562401-26-000032.md) | [49.5](/filings/0001562401-26-000047.md) |
| Net income | $m | [88.1](/filings/0001562401-24-000082.md) | [90.9 d](/filings/0001562401-26-000010.md) | [128](/filings/0001562401-25-000082.md) | [109](/filings/0001562401-25-000082.md) | [87.6](/filings/0001562401-25-000082.md) | [144 d](/filings/0001562401-26-000010.md) | [129](/filings/0001562401-26-000047.md) | [124](/filings/0001562401-26-000047.md) | [117](/filings/0001562401-25-000082.md) | [144 d](/filings/0001562401-26-000010.md) | [149](/filings/0001562401-26-000047.md) | [133](/filings/0001562401-26-000047.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001562401-24-000082.md) | not reported | [0.30](/filings/0001562401-25-000037.md) | [0.25](/filings/0001562401-25-000067.md) | [0.20](/filings/0001562401-25-000082.md) | not reported | [0.30](/filings/0001562401-26-000032.md) | [0.28](/filings/0001562401-26-000047.md) | [0.27](/filings/0001562401-25-000082.md) | not reported | [0.35](/filings/0001562401-26-000032.md) | [0.31](/filings/0001562401-26-000047.md) |
| Basic EPS | $ per share | [0.20](/filings/0001562401-24-000082.md) | not reported | [0.30](/filings/0001562401-25-000037.md) | [0.25](/filings/0001562401-25-000067.md) | [0.20](/filings/0001562401-25-000082.md) | not reported | [0.30](/filings/0001562401-26-000032.md) | [0.28](/filings/0001562401-26-000047.md) | [0.27](/filings/0001562401-25-000082.md) | not reported | [0.35](/filings/0001562401-26-000032.md) | [0.31](/filings/0001562401-26-000047.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001562401-24-000082.md) | [0.1](/filings/0001562401-26-000010.md) | [0.1](/filings/0001562401-25-000037.md) | [0.7](/filings/0001562401-25-000067.md) | [0.2](/filings/0001562401-25-000082.md) | [0.2](/filings/0001562401-26-000047.md) | [0.1](/filings/0001562401-26-000032.md) | [0.3](/filings/0001562401-26-000047.md) | [0.0](/filings/0001562401-25-000082.md) | [0.1](/filings/0001562401-26-000047.md) | [0.1](/filings/0001562401-26-000032.md) | [0.1](/filings/0001562401-26-000047.md) |
| Total assets | $bn | [12.6](/filings/0001562401-23-000123.md) | [12.7](/filings/0001562401-25-000013.md) | [12.8](/filings/0001562401-24-000053.md) | [13.3](/filings/0001562401-24-000069.md) | [12.8](/filings/0001562401-24-000082.md) | [13.4](/filings/0001562401-26-000010.md) | [13.3](/filings/0001562401-25-000037.md) | [13.6](/filings/0001562401-25-000067.md) | [13.3](/filings/0001562401-25-000082.md) | [13.2](/filings/0001562401-26-000047.md) | [13.2](/filings/0001562401-26-000032.md) | [13.1](/filings/0001562401-26-000047.md) |
| Total liabilities | $bn | [5.0](/filings/0001562401-23-000123.md) | [5.0](/filings/0001562401-25-000013.md) | [5.1](/filings/0001562401-24-000053.md) | [5.6](/filings/0001562401-24-000069.md) | [5.1](/filings/0001562401-24-000082.md) | [5.5](/filings/0001562401-26-000010.md) | [5.4](/filings/0001562401-25-000037.md) | [5.7](/filings/0001562401-25-000067.md) | [5.4](/filings/0001562401-25-000082.md) | [5.5](/filings/0001562401-26-000047.md) | [5.6](/filings/0001562401-26-000032.md) | [5.6](/filings/0001562401-26-000047.md) |
| Long-term debt | $bn | [4.4](/filings/0001562401-23-000123.md) | [4.5](/filings/0001562401-25-000013.md) | [4.5](/filings/0001562401-24-000053.md) | [5.0](/filings/0001562401-24-000069.md) | [4.5](/filings/0001562401-24-000082.md) | [5.0](/filings/0001562401-26-000010.md) | [4.9](/filings/0001562401-25-000037.md) | [5.2](/filings/0001562401-25-000067.md) | [4.8](/filings/0001562401-25-000082.md) | [5.1](/filings/0001562401-26-000047.md) | [5.1](/filings/0001562401-26-000032.md) | [5.1](/filings/0001562401-26-000047.md) |
| Shareholders' equity | $bn | [6.9](/filings/0001562401-23-000123.md) | [7.0](/filings/0001562401-25-000013.md) | [7.0](/filings/0001562401-24-000053.md) | [7.0](/filings/0001562401-24-000069.md) | [7.0](/filings/0001562401-24-000082.md) | [7.2](/filings/0001562401-26-000010.md) | [7.2](/filings/0001562401-25-000037.md) | [7.2](/filings/0001562401-25-000067.md) | [7.2](/filings/0001562401-25-000082.md) | [7.0](/filings/0001562401-26-000047.md) | [6.9](/filings/0001562401-26-000032.md) | [6.8](/filings/0001562401-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [208 d](/filings/0001562401-24-000082.md) | [115 d](/filings/0001562401-26-000010.md) | [202](/filings/0001562401-25-000037.md) | [274 d](/filings/0001562401-25-000067.md) | [234 d](/filings/0001562401-25-000082.md) | [102 d](/filings/0001562401-26-000010.md) | [223](/filings/0001562401-26-000032.md) | [272 d](/filings/0001562401-26-000047.md) | [223 d](/filings/0001562401-25-000082.md) | [146 d](/filings/0001562401-26-000010.md) | [203](/filings/0001562401-26-000032.md) | [293 d](/filings/0001562401-26-000047.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [79.9 d](/filings/0001562401-24-000082.md) | [79.9 d](/filings/0001562401-26-000010.md) | [95.9](/filings/0001562401-25-000037.md) | [95.6 d](/filings/0001562401-25-000067.md) | [95.6 d](/filings/0001562401-25-000082.md) | [96.4 d](/filings/0001562401-26-000010.md) | [112](/filings/0001562401-26-000032.md) | [112 d](/filings/0001562401-26-000047.md) | [112 d](/filings/0001562401-25-000082.md) | [111 d](/filings/0001562401-26-000010.md) | [121](/filings/0001562401-26-000032.md) | [119 d](/filings/0001562401-26-000047.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [349](/filings/0001562401-23-000123.md) | [361](/filings/0001562401-24-000053.md) | [362](/filings/0001562401-24-000069.md) | [363](/filings/0001562401-24-000082.md) | [367](/filings/0001562401-25-000037.md) | [367](/filings/0001562401-25-000067.md) | [368](/filings/0001562401-25-000082.md) | [371](/filings/0001562401-26-000032.md) | [371](/filings/0001562401-26-000047.md) | [372](/filings/0001562401-25-000082.md) | [364](/filings/0001562401-26-000032.md) | [361](/filings/0001562401-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.